The Haemostatic Mechanism and Menstruation: The Role of Intra-Uterine Contraceptive Devices

Summary

The haemostatic mechanism of 40 female patients undergoing menstruation, 20 with intra-uterine devices (IUCD) and 20 without (Control), were studied. The patients’ coagulation profiles, fibrinolytic system and platelet functions were studied before and after hysterectomy. Platelet survival times and platelet consumption was determined using ⁵¹Cr. labelled autologous platelets. Patients who menstruated during the study had their pads collected and radioactivity measured. Histology, autoradiography and scintillation counting was performed on uteri obtained from a hysterectomy performed towards the end of the platelet survival study period. There were no significant differences in the coagulation, fibrinolytic and platelet function tests in these 2 groups, though in each group there were the expected changes after operation.

Platelet survival time, consumption and radioactivity in the tampons showed no significant differences between the IUCD and control groups, although there were 6 patients with low platelet survival times in the IUCD group. Resected uteri showed surprising lack of concentration of platelets which may have been due in part to loss of blood at operation and handling of the uterus. Surprisingly, in the control patients, platelet survival time in response to the severe haemosatic challenge of menstruation were normal. However in the IUCD group, 6 patients showed shortening of platelet survival. Also surprisingly and equally in both control and IUCD groups, was the small amount of platelet related radioactivity in the menstruating fluid.

• References

• 1 Aas K, Gardner FH. 1958; Survival of blood platelets labelled with chromium 51. Journal of Clinical Investigation 37: 1257
• 2 Alkjaersig N, Fletcher AP, Sherry S. 1959; The mechanism of clot dissolution by plasmin. Journal of Clinical Investigation 38: 1086
• 3 Aparicio SR, Bradbury K, Bird CC, Foley ME, Jenkins DM, Clayton JK, Scott JS, Rajah SM, McNicol GP. 1979; Effect of intrauterine contraceptive devices on uterine haemostasis: a morphological study. British Journal of Obstetrics & Gynaecology 86: 314
• 4 Aster RH, Jandl JH. 1964; Platelet sequestration in man. I. Methods. Journal of Clinical Investigation 43: 843
• 5 Biggs R. 1972. Human blood coagulation. Haemostasis and Thrombosis. Blackwell Publications; London:
• 6 Bloch B, Kort H. 1977; Thrombocytopathia as a cause of menorrhagia. 2 case reports. British Journal of Obstetrics and Gynaecology 84: 956
• 7 Bonnar J, Kasonde K, Haddon M, Hassanein M, Allington MJ. 1976; Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices. British Journal of Obstetrics and Gynaecology 83: 160
• 8 Born GV R, Cross JJ. 1963; The aggregation of blood platelets. Journal of Physiology, London 168: 178
• 9 Bowie WE J, Owen CA, Thompson JH, Didisheim P. 1969; Platelet adhesiveness in von Willebrand’s disease. American Journal of Clinical Pathology 52: 69
• 10 Breckenridge RT, Ratnoff OD. 1962; Studies on the nature of the circulating anticoagulant directed against antihaemophilic factor: with notes on the assay for antihaemophilic factor. Blood 20: 137
• 11 Cohen P, Gardner FH, Barnett GO. 1961; Reclassification of the thrombocytopenias by the Cr.51 labelling method for measuring platelet lifespan. New England Journal of Medicine 264: 1350
• 12 Dubber AH C, McNicol GP, Uttlev D, Douglas AS. 1968; In vitro and in vivo studies with Trasylol an anticoagulant and a fibrinolytic inhibitor. British Journal of Haematology 14: 31
• 13 Eichelberger Jr JW. 1965. Laboratory methods in blood coagulation. Harper and Row Publications; New York:
• 14 Hog S, Cash JD. 1973; Studied on a direct latex agglutination of fibrin/fibrinogen degradation products. Thrombosis Research 2: 23
• 15 Howie PW, Prentice CR M, McNicol GP. 1973; A method of antithrombin estimation using plasma defibrinated with Acrod. British Journal of Haematology 25: 101
• 16 Kasonde J, Bonnar J. 1976; Plasminogen activators inthe endometrium of women using intrauterine contraceptive devices. British Journal of Obstetrics and Gynaecology 83: 315
• 17 Langdell RD, Wagner RH, Brinkhouse KM, Hill CM C. 1953; Effect of antihaemophilic factor on one-stage clotting tests. Journal of Laboratory and Clinical Medicine 41: 637
• 18 Manohitharajah SM, Rahman AN, Donnelly RJ, Deverall PB, Watson DA. 1974; Platelet survival in patients with homograft and prosthetic heart valves: correlation with incidence of thromboembolism. Thorax 29: 639
• 19 Murphy S, Gardner FH. 1969; Platelet preservation. Effect of storage temperature on maintenance of platelet viability - deleterious effect of refrigerated storage New England Journal of Medicine 280: 1094
• 20 Nilsson IM, Olow B. 1962; Fibrinolysis induced by streptokinase in man. Acta Chirurgica Scandinavia 123: 247
• 21 Quick A, Stanley-Brown M, Bancroft FW. 1935; A study of the coagulation defect in haemophilia and in jaundice. American Journal of Medical Science 190: 501
• 22 Rajah SM. 1976; Platelet survival in patients with homograft and prosthetic heart valves: correlation with incidence of thrombo-embolism (abstract). British Journal of Haematology 33: 148
• 23 Ratnoff OD, Menzie C. 1951; A new method for determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 37: 316
• 24 Spaet TH, Cintron J. 1973; Studies on platelet factor 3 availability. British Journal of Haematology 25: 101
• 25 Welly HS, Steele PP, Genton E. 1972; Platelet survival in patients with a Beall valve. Relation to low incidence of thromboembolism The American Journal of Cardiology 30: 229
• 26 The Panel on Diagnostic Application of Radioisotopes in Haematology, International Committee for Standardisation in Haematology. Recommended methods for Radioisotope platelet survival studies. Blood 50: 1137